Disease modifying drugs
Disease modifying drugs are a group of treatments for people with relapsing remitting multiple sclerosis.
They reduce the number of relapses you might experience as well as reducing the severity of any relapses you do have.
There are 12 drugs approved for use by the NHS in the UK.
Guide to decision making
This guide will help you think through the issues that are involved in choosing a disease modifying drug. Many of these are personal to you and your views, preferences and attitude to risk are an important part of weighing up the pros and cons of treatment, as well as considering how family and work might affect your decision.
Frequently asked questions (FAQs) and key terms
The frequently asked questions (FAQs) answer some of most commonly asked questions about DMDs. It covers questions you may have about considering, starting and living with treatment.
The key terms page explains words and phrases used within MS Decisions.
About MS Decisions
MS Decisions was established in 2004 as an independent source of reliable, evidence-based information for anyone wanting to know more about the disease modifying drugs for relapsing remitting MS.
This latest version has been updated in 2017 to include all 12 drugs approved for use by the NHS in the UK.